Home / Feed item / OIRM: 60% of AML patients relapse: study finds molecular players that help cancer stem cells evade treatmentshttp://www.ncbi.nlm.nih.gov/pubmed/28187429 #PubMedCrawl
OIRM: 60% of AML patients relapse: study finds molecular players that help cancer stem cells evade treatmentshttp://www.ncbi.nlm.nih.gov/pubmed/28187429 #PubMedCrawl
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
